Transfusion Medicine最新文献

{"title":"D-- phenotype in a South Indian family: A multicentric approach to workup and management.","authors":"Soumee Banerjee, Pooja D Kshirsagar, Ankit Mathur, Swati Kulkarni, T V Reddy","doi":"10.1111/tme.13137","DOIUrl":"https://doi.org/10.1111/tme.13137","url":null,"abstract":"<p><strong>Background: </strong>The Rh system is an extremely important blood group system with over 50 antigens, 5 of which (D, C, E, c and e) are considered most clinically significant. Rare Rh deficient phenotypes include D--, which is a blood group characterised by the lack of expression of C, c, E and e and exalted expression of the D antigen on the red cells due to mutations in both alleles of the RHCE gene. This is a multicentre approach to a case of the rare D-- phenotype.</p><p><strong>Case report: </strong>A 56-year-old lady with bad obstetric history presenting with severe anaemia had to be evaluated for a panreactive antibody affecting cross-matching. On identifying a D-- phenotype by serology, a thorough family study was performed on 18 of her first and second-degree relatives. Three family members were also found to be of the rare phenotype, one of whom was pregnant. This relative was counselled appropriately and provided with an overview of her phenotype for her obstetric care team. Molecular analysis by QMPSF confirmed the serological findings. This case eventually became the motivation behind an institutional \"rare donor\" registry programme.</p><p><strong>Results: </strong>Serology revealed a panreactive antibody affecting cross-matches. Her Rh phenotype was D+, C-, c-, E-, e-, K-, k+. Molecular analysis on her and three family members suggested homozygous CE-D hybrid alleles causing the D-- phenotype: RHCE-D(3-9)-CE.</p><p><strong>Conclusion: </strong>D-- is an uncommon phenotype and was found to occur in a cluster in this family. Like most difficult immunohematological cases, it mandated a multicentric and a multi-technique approach to resolve.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143773357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Frequency of RHD variants among blood donors in the central region of Iran, Yazd province.","authors":"N Seddighi, A Oodi, F Zare, H Javadzadeh Shahshahani","doi":"10.1111/tme.13135","DOIUrl":"https://doi.org/10.1111/tme.13135","url":null,"abstract":"<p><strong>Background and aims: </strong>D antigen is a crucial factor in both blood transfusions and haemolytic disease of foetus/newborn (HDFN). Some variants of the D antigen can produce anti-D and should be considered Rh-negative, while others are Rh-positive and can receive Rh-positive blood. Efficient and cost-effective genotype tests in the management of Rh-negative blood usage and preventive management of HDFN require knowledge of the distribution of RHD variant alleles among different populations. The aim of this study was to determine the frequency of weak D/partial D variants in blood donors of Yazd Blood Center.</p><p><strong>Materials and methods: </strong>Between October 2022 and October 2023, 43 blood samples with weak D antigen expression from blood donors at Yazd Blood Center were analysed. The samples' phenotypes were identified using serological methods to detect the e, c, E, C, and D antigens. The D variant-associated alleles were evaluated using polymerase chain reaction-SSP, restriction fragment length polymorphism, and DNA sequencing techniques.</p><p><strong>Results: </strong>The result showed four different weak D and one Partial D allele. The highest prevalence was related to RHD* weak partial 15 (48.8%), followed by RHD*01W.80 (18.6%), RHD*01W.1 (4.6%), and RHD*01W.4 (2.3%). There were seven cases (16.2%) of RHD*Partial DLO. This study showed the association between weak D type 15 and antigens E.</p><p><strong>Conclusion: </strong>The results of this study highlight the specific pattern of RHD variants in the Yazd population. Weak D type 15 showed the highest prevalence, while weak D type 80 was particular to the Yazd region.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143765118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An 8-year retrospective review of human albumin solution use August 2015 to March 2023; Guy's and St Thomas' NHS Foundation Trust.","authors":"Asma Tameez Ud Din, Patrick Harrington, Danaee Anicee, Andrew Retter, Llywelyn Cadman-Davies, Muhammad Sajid Yazdani, Paul Holmes, Vickie McDonald, Susan E Robinson","doi":"10.1111/tme.13138","DOIUrl":"https://doi.org/10.1111/tme.13138","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study is to critically assess the diverse indications for HAS administration over the past 8 years at a prominent tertiary care institution in the United Kingdom.</p><p><strong>Background: </strong>This is timely and relevant, given recent developments in the field. The International Collaborative Transfusion Medicine Group (ICTMG) issued updated guidance on intravenous albumin use in March 2024, reflecting a shift towards more stringent criteria for its application, which necessitates a re-evaluation of current practices.</p><p><strong>Method: </strong>We conducted a retrospective analysis of the usage of HAS from August 2015 to March 2023. Records of all patients who received HAS during this study period were extracted from the Electronic Patient Records (EPR) of Guys and St Thomas' NHS Foundation Trust London (GSTFT). Data analysis was performed using SPSS version 20.</p><p><strong>Results: </strong>A total of 4816 patients received HAS during the audit period, with 21 231 HAS infusions. The majority of infusions were for 20% HAS, with 16 772 (79% of total) infusions for 20% HAS in 4145 patients. A total of 4459 (21%) infusions were recorded for 4.5 and 5% HAS.</p><p><strong>Conclusion: </strong>Our study provides a comprehensive analysis of albumin utilisation and TPE indications over the past 8 years at our institution, establishing a crucial baseline for refining our practices.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143744047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Frequencies of different blood group antigens and phenotypes in Northern Vietnamese donors.","authors":"Tung Quang Nguyen, Tuyen Thi Do, Nga Thanh Thi Hoang, Khanh Quoc Bach, Thanh Ha Nguyen","doi":"10.1111/tme.13136","DOIUrl":"https://doi.org/10.1111/tme.13136","url":null,"abstract":"<p><strong>Background and objectives: </strong>Blood safety is the top priority in transfusion medicine. However, patients in Vietnam are only transfused with ABO and RhD compatible blood products, which could pose a threat to induce alloimmunization. This study was performed to provide information about the frequencies of antigens and phenotypes of clinically significant blood groups in Vietnamese donors.</p><p><strong>Materials and methods: </strong>Blood samples were taken from donors to identify red cell antigens by column agglutination tests. Antigen and phenotype frequencies were calculated and expressed as percentages. Gene frequencies were calculated under the standard assumption of Hardy-Weinberg equilibrium.</p><p><strong>Results: </strong>Among the Rh antigens, e was the most common (96.96%) followed by D (96.72%), C (92.86%), c (43.10%), and E (32.59%) with D+C+E-c-e+(54.02%) being the most common phenotype. In the Lewis and Duffy blood group system, the major phenotypes found were Le (a-b+) (60.43%) and Fy (a+b-) (85.39%), respectively. In the Kell and Lutheran blood group system, k and Lu^b were present in 100% of the donors, respectively. The most common phenotypes in the Kidd and MNS blood group system were Jk (a+b+) (47.62%) and M + N+(46.63%), S-s+ (94.42%), respectively. Mi^a was seen in 9.20% of the donors. The frequency of P1 was 22.25%.</p><p><strong>Conclusion: </strong>This study shows the frequencies of 21 blood group antigens in Northern Vietnam donors. Knowledge of red cell antigen phenotype frequencies can help prepare indigenous cell panels, provide antigen-negative blood to patients with multiple alloantibodies, and prevent alloimmunisation.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anti-Ce in haemolytic disease of the foetus and newborn.","authors":"Rebecca O'Grady, Joan Fitzgerald, Jan Miletin, Carmen Regan, Fergus Guilfoyle, Edel Scally, Catherine Flynn","doi":"10.1111/tme.13134","DOIUrl":"https://doi.org/10.1111/tme.13134","url":null,"abstract":"<p><strong>Objectives: </strong>To report a delayed case of severe haemolytic disease of the foetus and newborn (HDFN) due to Anti-Ce.</p><p><strong>Background: </strong>HDFN due to maternal antibodies is potentially fatal. As a result, antibody levels and foetal anaemia are periodically monitored and risk assessed throughout pregnancy. HDFN due to Anti-Ce is rare.</p><p><strong>Case report: </strong>A 29-year-old Caucasian female with low titre Anti-Ce and Anti-e antenatally delivered a term baby girl that required multiple transfusions and hospital admissions early in life. The apparent clinical severity of HDFN resulted in investigative testing of a maternal admission sample at delivery for titre levels. Anti-Ce was identified as the cause of HDFN in this case, following an eightfold increase in titre levels from week 28 gestation (titre = 4) to term (titre = 32).</p><p><strong>Discussion: </strong>The severe HDFN outlined in this case was unexpected due to the antibody specificity and low titres antenatally. The Anti-Ce with a titre of 32 implicated in this study is on the threshold for specialist foetal team involvement and vigilant monitoring as per BSH guidelines.</p><p><strong>Conclusion: </strong>Anti-Ce titre monitoring beyond 28 weeks gestation and specialist foetal team involvement early in pregnancy should be considered despite current BSH Guidelines, along with extended neonatal monitoring.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143568342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The experience of the Turkish Red Crescent blood banks in the 2023 Türkiye earthquake.","authors":"Aziz Karaca, Levent Sağdur, Mustafa Nuri Günçıkan, Mustafa Yılmaz, Nazlı Sözmen, Kerem Kınık, Fatma Meriç Yılmaz","doi":"10.1111/tme.13129","DOIUrl":"https://doi.org/10.1111/tme.13129","url":null,"abstract":"<p><strong>Aim: </strong>This cross-sectional study aimed to determine the impact of a severe earthquake on blood donation as per blood safety and donation behaviour.</p><p><strong>Materials and methods: </strong>This retrospective cross-sectional study included a total of 263 779 whole-blood donors at the Turkish Red Crescent during two periods: before (25 January 2023 - 5 February 2023) and after (6 February 2023 - 17 February 2023) the earthquake that occurred on 6 February 2023. Demographic data describing the donors, donor types, the number of blood donations by province, blood donations by blood groups, hospital demand, and transfusion transmissible infection (TTI) rates according to donor type were evaluated.</p><p><strong>Results: </strong>There was a 129% increase in blood donations after the earthquake. his increase was significant among female donors, younger age groups, and first-time donors. However, a significant increase in TTI rates was not detected in either first time donors or repeat donors.</p><p><strong>Conclusion: </strong>Our study focuses on blood banking activities of the Turkish Red Crescent during the 2023 Türkiye earthquake. While previous disasters have shown excess blood collection, we emphasise the need for a balanced approach to avoid wastage and shortages. Our study emphasises the importance of efficient blood utilisation and the necessity of regular, voluntary blood donations to ensure a stable supply, especially for high-demand blood groups like O Rh (-).</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Red blood cell inventory management: Insights from transfusion laboratory technologists in British Columbia, Canada.","authors":"Jasdeep Dhahan, Douglas Morrison, Andrew W Shih, Deb McDonald, Robby Chen, Lillian Hao, Kristin Rosinski, Sarah Buchko, John Blake, Alexander Rutherford","doi":"10.1111/tme.13131","DOIUrl":"https://doi.org/10.1111/tme.13131","url":null,"abstract":"<p><strong>Background and objectives: </strong>There is concern about sustaining the O negative blood supply, especially in areas with many rural/remote hospitals like British Columbia. Red blood cells are perishable, making inventory management challenging. Demand must be met without wasting this precious resource. Inventory management challenges stem from data scarcity and human factors. Transfusion medicine technologists, who manage inventory daily, are key to understanding the human factors in inventory management. We conducted a qualitative study to understand technologists' inventory management perspectives and experiences, particularly for group O negative red blood cells, aiming to inform future inventory modelling to address human factors.</p><p><strong>Materials and methods: </strong>We interviewed transfusion laboratory technologists and technical leads from all health authorities and a blood product supplier representative for the Province of British Columbia. Thematic analysis of the interview transcripts was conducted.</p><p><strong>Results: </strong>We found five themes that influence technologist decision-making on RBC inventory management, key challenges for O-negative RBCs, and identified inventory management strategies. We compare the top three inventory practices from our results with literature.</p><p><strong>Conclusions: </strong>Our findings help bridge the knowledge gap concerning human factors in RBC inventory management, with potential generalizability to other jurisdictions. They hold promise for informing the safeguarding of donors' altruistic contributions.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143442114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development and validation of an indigenous questionnaire for assessing clinician's knowledge towards transfusion medicine and bedside transfusion practices.","authors":"Anubhav Gupta, Hari Krishan Dhawan, Romesh Jain, Ratti Ram Sharma, Vipin Kaushal, Amarjeet Singh, Neelam Marwaha","doi":"10.1111/tme.13130","DOIUrl":"https://doi.org/10.1111/tme.13130","url":null,"abstract":"<p><strong>Introduction: </strong>Due to the non-availability of formal training during residency for clinicians in transfusion medicine, there is a prevalent knowledge gap for transfusion practices, which leads to increased patient risks and elevated healthcare costs. There is no indigenous questionnaire available, which could be used for knowledge assessment. This study aims to develop and validate an Indigenous questionnaire to assess clinicians' knowledge of transfusion medicine and bedside transfusion practices.</p><p><strong>Materials and methods: </strong>The questionnaire was designed using a nominal group technique involving subject experts, considering the type of information required, themes, appropriate wording, layout, and presentation. The questionnaire consisted of 25 knowledge-based questions and 4 general questions. Piloting of the questionnaire was done to check for feasibility, validation, and reliability. Content validity was assessed by six experts using the Content Validity Index (CVI). Reliability was assessed using test-retest and split-half methods, with a sample of 56 participants. Cronbach's alpha and Kappa statistics were used to measure internal consistency and agreement, respectively.</p><p><strong>Results: </strong>The questionnaire displayed acceptable feasibility with a mean difficulty score of 6.93 on a scale of 1-10, with test-retest responses showing near-perfect agreement (kappa value 0.8-0.99). All experts gave more than 70% agreement on the relevance of content, with a mean CVI of 85%. Test-retest reliability showed near-perfect agreement (Kappa 0.8-0.99, p = 0.008) and good internal consistency (Cronbach's α = 0.806). The split-half method yielded a Cronbach's α of 0.89 and an intraclass correlation coefficient of 0.88 (95% CI 0.57, 0.97, p = 0.001) Construct validity was confirmed through factor analysis.</p><p><strong>Conclusion: </strong>The developed indigenous questionnaire is a reliable and valid tool for assessing the knowledge of clinicians towards transfusion medicine and bedside transfusion practices. The detailed, methodical strategy used to prepare and validate the questionnaire ensures its applicability and relevance in various clinical settings and can be easily adopted by others intending to prepare similar questionnaires. The questionnaire is available with the author and, on demand, may be provided for knowledge assessment.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143433066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prevalence of anaemia among blood donors in eastern Morocco: The need for pre-donation haemoglobin assessment.","authors":"Ihab Belmokhtar, Karam Yahya Belmokhtar, Saida Lhousni, Redouane Boulouiz, Zaina Sidqi, Mohammed Choukri, Rachid Seddik, Mohammed Bellaoui","doi":"10.1111/tme.13133","DOIUrl":"https://doi.org/10.1111/tme.13133","url":null,"abstract":"<p><strong>Background: </strong>Anaemia remains the main cause of deferral in blood donation. However, in Morocco, pre-donation haemoglobin measurement is not systematic.</p><p><strong>Objectives: </strong>The aim of this study was to determine the prevalence of anaemia and associated factors such as sex, age and iron deficiency among blood donors in eastern Morocco in order to improve donor management practices.</p><p><strong>Methods/materials: </strong>The study involved 2013 blood donors from the BRO Biobank. Blood samples were analysed using an automatic blood cell analyser for complete blood counts. Serum ferritin was measured by chemical and immunological analyser. Anaemia was defined as haemoglobin levels less than 13 g/dL in men and 12 g/dL in women, according to the WHO recommendation.</p><p><strong>Results: </strong>The overall prevalence of anaemia in eastern Morocco was 9.84% and it varied significantly by region. The majority of anaemic individuals were iron-deprived (88.64%). Anaemia was much higher in females (14.74%) than in males (5.46%). The highest prevalence of anaemia among females was in the age group of 18-20 years (25.2%), while among males it was in the age group of 61-65 years (18.52%).</p><p><strong>Conclusions: </strong>The high prevalence of anaemia among blood donors in eastern Morocco highlights the need to implement pre-donation haemoglobin assessment in donor selection guidelines and to consider optional ferritin testing for at-risk populations. Moreover, educating donors about iron deficiency and iron-rich diets is essential for sustaining donor health and eligibility.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143415355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Early alloimmunization in an infant to red cell antigens-Rare but possible in the 'right' circumstances.","authors":"Anwen Maddock, Sue Warrington, Amanda Lyver, Krishna G Badami","doi":"10.1111/tme.13132","DOIUrl":"https://doi.org/10.1111/tme.13132","url":null,"abstract":"<p><strong>Background: </strong>Red blood cell (RBC) alloimmunization is rarely reported in infants less than 4-6 months of age.</p><p><strong>Methods/materials: </strong>Blood group and antibody screening used the gel card technique. All blood products were leukoreduced. All RBC doses transfused were group O, E-neg, K-neg but the pooled platelets transfused on day 45 and 61 included donors who were K-pos, and that transfused on day 61 also included an E-pos donor.</p><p><strong>Results: </strong>We report a group O neonate with haemophagocytic lymphohistiocytosis (HLH) who developed alloantibodies to E and K antigens at 65 days (9 weeks) of age.</p><p><strong>Conclusion: </strong>HLH is an inflammatory, 'hyperimmune' state, and alloimmunization is more likely when inflammation is present. If significant inflammation is present, transfusions should be avoided if possible.</p>","PeriodicalId":23306,"journal":{"name":"Transfusion Medicine","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2025-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143392019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}